4.8 Article

An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles

期刊

CANCER CELL
卷 35, 期 1, 页码 33-+

出版社

CELL PRESS
DOI: 10.1016/j.ccell.2018.12.001

关键词

-

资金

  1. NIH/NCI [PO1 CA165997]
  2. R01 grants [CA092900, CA216936, CA188575]
  3. PA Department of Health FY18 2017 Health Research Formula Fund
  4. Wellcome Trust [PRF 101835/Z/13/Z]
  5. MRC [CSF MR/P008801/1]
  6. NHSBT [WPA15-02]
  7. Pittsburgh-Essen-Partnership Program
  8. Undergraduate Student Scholars Program in the Center for Molecular Studies in Digestive and Liver Disease, University of Pennsylvania
  9. Merial Veterinary Scholars Program Fellowship
  10. [F32 CA206431]
  11. [T32 CA115299]
  12. [T32 CA009140]
  13. MRC [MR/P008801/1] Funding Source: UKRI

向作者/读者索取更多资源

Tumor-derived extracellular vesicles (TEV) educate'' healthy cells to promote metastases. We found that melanoma TEV downregulated type I interferon (IFN) receptor and expression of IFN-inducible cholesterol 25-hydroxylase (CH25H). CH25H produces 25-hydroxycholesterol, which inhibited TEV uptake. Low CH25H levels in leukocytes from melanoma patients correlated with poor prognosis. Mice incapable of down-regulating the IFN receptor and Ch25h were resistant to TEV uptake, TEV-induced pre-metastatic niche, and melanoma lung metastases; however, ablation of Ch25h reversed these phenotypes. An anti-hypertensive drug, reserpine, suppressed TEV uptake and disrupted TEV-induced formation of the pre-metastatic niche and melanoma lung metastases. These results suggest the importance of CH25H in defense against education of normal cells by TEV and argue for the use of reserpine in adjuvant melanoma therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据